z-logo
Premium
Buprenorphine kinetics
Author(s) -
Bullingham Roy E S,
McQuay Henry J,
Moore Andrew,
Bennett Martin R D
Publication year - 1980
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1980.219
Subject(s) - buprenorphine , anesthesia , medicine , radioimmunoassay , pharmacokinetics , pain relief , kinetics , clinical pharmacology , half life , plasma concentration , pharmacology , chemistry , opioid , physics , receptor , quantum mechanics
Buprenorphine kinetics was determined in surgical patients using radioimmunoassay. Buprenorphine was measured in the plasma of 24 patients who had received 0.3 mg buprenorphine intraoperatively. After 3 hr 10 of these patients then received a further 0.3 mg buprenorphine intravenously for postoperative pain relief, and 11 patients were given 0.3 mg intramuscularly: again, plasma levels were measured for 3 hr. The data fitted closely to a triexponential decay curve. There was a very fast initial phase, with a half‐life (t½) of 2 min. The terminal t½ was slow, approximately 3 hr. Comparison of the kinetics of the same patient, awake and anesthetized, showed that the clearance was significantly lower in the anesthetized state. A notable feature of the drug given intramuscularly is rapid systemic availability, so that peaks are obtained in 2 to 5 min, and in 10 min the resulting levels are the same as for the intravenous and intramuscular routes. Clinical Pharmacology and Therapeutics (1980) 28, 667–672; doi: 10.1038/clpt.1980.219

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom